APLS Q1 2018 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$21M

Operating Income

-$21M

Net Income

-$22M

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$163M

Total Liabilities

$34M

Stockholders' Equity

$129M

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$21M	$0	—
Operating Income	-$21M	-$9M	-136.8%
Net Income	-$22M	-$9M	-140.2%